Global Peptide Therapeutics Market & Clinical Trials Insight 2017-2022 - Clinical & Patent Insight on 119 Marketed Peptides - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Peptide Therapeutics Market & Clinical Trials Insight 2022" report to their offering.

Global Peptide Therapeutics Market & Clinical Trials Insight 2022 report gives comprehensive insight into the various clinical and non-clinical issues involved in the development of global peptide drug market. In recent years, peptides have emerged as one of the important classes of therapeutic molecules which have been developed by varied pharmaceutical and biotech companies in order to attain a targeted drug discovery for several ailments. As per report findings, there are 688 peptide drugs in clinical pipeline and more than 100 peptide based drugs commercially available in the market.

Global Peptide Therapeutics Market & Clinical Trials Insight 2022 report highlights:

  • Fundamentals of Peptide Therapeutics
  • Peptide Therapeutics by Applications & Indications
  • Peptides Clinical Trials Insight by Phase, Indication & Company
  • Insight on 688 Peptide Drugs in Clinical Trials
  • Clinical & Patent Insight on 119 Marketed Peptides
  • Future Peptide Therapeutics Market Outlook

Key Topics Covered:

1. A Revolution of Peptide Therapeutics

2. Cusp of Small Molecules & Proteins

3. Fundamentals of Peptide Therapeutics

4. Peptide Therapeutics by Applications

5. Peptide Therapeutics in Metabolic Disorder

6. Peptide Therapeutics in Cancer

7. Peptide Therapeutics in Cardiovascular

8. Peptide Therapeutics in HIV & Infections

9. Peptide Therapeutics in CNS Disorders

10. Global Peptide Therapeutics Market

11. Global Peptide Market by Administration

12. Global Peptides Clinical Trials Overview

13. Global Peptide Market by Region

14. Global Peptide Market Dynamics

15. Future Peptide Therapeutics Market Outlook

16. Cyclic Peptides Clinical Trials Insight by Phase, Indication & Company

17. Depsipeptides Clinical Trials Insight by Phase, Indication & Company

18. Dipeptides Clinical Trials Insight by Phase, Indication & Company

19. Glycopeptides Clinical Trials Insight by Phase, Indication & Company

20. Glucagon-Like Peptides Clinical Trials Insight by Phase, Indication & Company

21. Lipopeptides Clinical Trials Insight by Phase, Indication & Company

22. Natriuretic Peptides Clinical Trials Insight by Phase, Indication & Company

23. Neuropeptides Clinical Trials Insight by Phase, Indication & Company

24. Oligopeptides Clinical Trials Insight by Phase, Indication & Company

25. Opioid Peptides Clinical Trials Insight by Phase, Indication & Company

26. Peptides Clinical Trials Insight by Phase, Indication & Company

27. Peptide Antibiotics Clinical Trials Insight by Phase, Indication & Company

28. Peptide Aptamers Clinical Trials Insight by Phase, Indication & Company

29. Peptide Hormones Clinical Trials Insight by Phase, Indication & Company

30. Peptide Fragments Clinical Trials Insight by Phase, Indication & Company

31. Multiple Peptides Clinical Trials Insight by Phase, Indication & Company

32. Competitive Landscape

  • Amgen
  • Amylin Pharmaceuticals
  • Apitope Technology
  • BiondVax Pharmaceuticals Ltd
  • BioPartners
  • Boehringer Ingelheim
  • Circassia
  • Corden Pharma (Peptisyntha)
  • Eli Lily
  • Galena Biopharmaceuticals
  • GlaxoSmithKline
  • Hyperion Therapeutics
  • ImmunoCellular Therapeutics
  • Ipsen
  • Lonza
  • Merck
  • NovoNordisk
  • Par Pharmaceuticals
  • PeptiDream
  • Roche
  • Sanofi
  • Tarix Pharmaceuticals

For more information about this report visit http://www.researchandmarkets.com/research/xqqf28/global_peptide

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials, Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials, Biopharmaceuticals